ANG Lifesciences India Ltd

On 28-Nov, ANG Lifesciences India Ltd witnessed a notable intraday price increase of 4.99%, closing at ₹27.98, reflecting a positive short-term momentum despite its challenging longer-term performance against the broader market benchmarks.

ANG Lifesciences has experienced a significant decline in net sales and profitability, with net sales dropping from INR 354.30 crore in March 2022 to INR 92.85 crore in March 2025, and profit after tax turning from a profit of INR 40.32 crore to a loss of INR 12.41 crore in the same period. The company's total assets and liabilities also decreased, and cash flow from operating activities fell to zero in March 2025.

ANG Lifesciences' latest results show a mixed performance, with net sales increasing by 33.62% year-on-year to Rs 24.60 crore, but a net loss of Rs -2.01 crore indicates ongoing challenges; overall, there are signs of recovery, but the financial outlook remains complex.

As of 13-Nov, ANG Lifesciences India Ltd's stock price is 29.88, down 2.26%, and has underperformed its sector and the benchmark Sensex significantly, with a year-to-date decline of 33.14%. The stock is in a bearish trend, trading below all major moving averages and experiencing reduced investor participation.

ANG Lifesciences will announce its results on 14 November 2025.

As of 28-Oct, ANG Lifesciences India Ltd's stock price is 32.69, down 0.91%, and has underperformed its sector today. Despite a recent short-term gain, the stock has significant long-term declines, including a 26.85% drop year-to-date and a 77.45% decline over three years, contrasting sharply with the broader market's positive performance.

As of 27-Oct, ANG Lifesciences India Ltd's stock price has risen to Rs 32.99, up 3.35%, and has outperformed its sector recently, despite a year-to-date decline of 26.18%. The increase in delivery volume suggests heightened investor interest, contributing to its short-term performance, which has outpaced the benchmark Sensex.

As of 15-Oct, ANG Lifesciences India Ltd's stock price is declining at 31.40, down 1.01%, with a total drop of 6.99% over the last four days and a year-to-date decline of 29.74%. This underperformance contrasts sharply with the broader market, which has gained 5.72% year-to-date.

As of 08-Oct, ANG Lifesciences India Ltd's stock price is Rs 32.94, down 3.63% after a four-day decline, reflecting a 33.75% drop over the past year. The company's weak fundamentals, high debt, and negative operating profits contribute to its underperformance compared to the market.

As of 01-October, ANG Lifesciences India Ltd's stock price is Rs 35.40, up 4.98% today, but it has declined 1.42% over the past week and 20.79% year-to-date. Despite recent gains and outperforming the Sensex today, long-term performance remains weak with a 76.25% drop over three years.

As of 26-Sep, ANG Lifesciences India Ltd's stock price is Rs 33.57, down 4.85%, continuing a downward trend with significant operating losses and a high Debt to EBITDA ratio. The company has reported negative results for 12 consecutive quarters, leading to poor investor sentiment and underperformance compared to the broader market.